Crossmark

Proton linac-based therapy facility for ultra-high dose rate (FLASH) treatment

Crossref DOI link: https://doi.org/10.1007/s41365-021-00872-4

Published Online: 2021-04-08

Published Print: 2021-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fang, Wen-Cheng https://orcid.org/0000-0002-4707-7414
Huang, Xiao-Xia https://orcid.org/0000-0002-5807-944X
Tan, Jian-Hao https://orcid.org/0000-0002-7743-024X
Wang, Chao-Peng

Xiao, Cheng-Cheng https://orcid.org/0000-0001-7431-9194
Lu, Yi-Xing https://orcid.org/0000-0002-6653-9514
Zhang, Yu https://orcid.org/0000-0002-6845-7088
Yang, Yu-Qing

Xu, Yi-Ming

Gong, Han-Yu

Zhang, Jun-Qiang https://orcid.org/0000-0002-5031-7693
Zhong, Shao-Peng

Zhao, Zhen-Tang
License Information

Text and Data Mining valid from 2021-04-01

Version of Record valid from 2021-04-01
More Information

Article History

Received: 11 January 2021

Revised: 20 February 2021

Accepted: 4 March 2021

First Online: 8 April 2021